(Q33742607)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

review article

1 reference

title

Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

6 references

13 March 2019

24 March 2019

22 April 2019

27 September 2019

27 November 2019

13 December 2019

familial Mediterranean fever

6 references

13 March 2019

24 March 2019

22 April 2019

27 September 2019

27 November 2019

13 December 2019

1 reference

27 September 2019

1 reference

27 November 2019

1 reference

13 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Aysa Hacioglu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yasaman Adibnia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Vedat Hamuryudan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Huri Ozdogan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

1 reference

30 May 2017

7 references

13 March 2019

24 March 2019

22 April 2019

27 September 2019

27 November 2019

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

Orphanet Journal of Rare Diseases

21 March 2020

published in

7 references

13 March 2019

24 March 2019

22 April 2019

27 September 2019

27 November 2019

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

21 March 2020

copyright license

6 references

13 March 2019

24 March 2019

22 April 2019

27 September 2019

27 November 2019

on focus list of Wikimedia project

13 December 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/s13023-017-0642-0

0 references

cites work

Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Non-response to colchicine in familial Mediterranean fever should be identified accurately

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Chronic inflammation in FMF: markers, risk factors, outcomes and therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Cytokine profile of Armenian patients with Familial Mediterranean fever

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Natural history and outcome in systemic AA amyloidosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Eprodisate for the treatment of renal disease in AA amyloidosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Evolving knowledge and therapy of inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

The importance of serial measurements of cytokine levels for the evaluation of their role in pathogenesis in familial Mediterraean fever.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Molecular mechanisms of amyloidosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Criteria for the diagnosis of familial Mediterranean fever

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Good medium-term efficacy of tocilizumab in DMARD and anti-TNF-α therapy resistant reactive amyloidosis

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-017-0642-0

Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-017-0642-0

Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-017-0642-0

Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-017-0642-0

Renal amyloidosis secondary to rheumatoid arthritis: remission of proteinuria and renal function improvement with tocilizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-017-0642-0

Tocilizumab treatment for nephrotic syndrome due to amyloidosis in Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-017-0642-0

Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-017-0642-0

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13023-017-0642-0

Remission of nephrotic syndrome due to AA-amyloidosis, complicating familiar Mediterranean fever, with tocilizumab

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Interleukin-6 targeting therapy in familial Mediterranean fever.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450086

Tocilizumab in amyloidosis-associated kidney disease secondary to inflammatory bowel diseases

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28558744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28558744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28558744

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S13023-017-0642-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

21 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28558744%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference